Envista Holdings Corporation (NYSE:NVST) Short Interest Up 32.8% in March
by Doug Wharley · The Cerbat GemEnvista Holdings Corporation (NYSE:NVST – Get Free Report) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 9,691,732 shares, an increase of 32.8% from the March 15th total of 7,296,729 shares. Based on an average daily volume of 2,379,616 shares, the short-interest ratio is currently 4.1 days. Currently, 6.0% of the shares of the company are short sold.
Insider Activity at Envista
In other Envista news, SVP Mischa Reis sold 9,675 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. The trade was a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.66% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Envista
A number of large investors have recently bought and sold shares of the company. Evolve Private Wealth LLC grew its stake in Envista by 4.0% during the first quarter. Evolve Private Wealth LLC now owns 100,794 shares of the company’s stock worth $2,557,000 after buying an additional 3,837 shares in the last quarter. Hsbc Holdings PLC grew its stake in Envista by 31.1% during the fourth quarter. Hsbc Holdings PLC now owns 83,350 shares of the company’s stock worth $1,821,000 after buying an additional 19,788 shares in the last quarter. Rockefeller Capital Management L.P. grew its stake in Envista by 1,654.2% during the fourth quarter. Rockefeller Capital Management L.P. now owns 12,385 shares of the company’s stock worth $269,000 after buying an additional 11,679 shares in the last quarter. Corient Private Wealth LLC grew its stake in Envista by 311.2% during the fourth quarter. Corient Private Wealth LLC now owns 92,259 shares of the company’s stock worth $2,003,000 after buying an additional 69,820 shares in the last quarter. Finally, Kera Capital Partners Inc. acquired a new stake in Envista during the fourth quarter worth about $392,000.
Envista Price Performance
Envista stock traded up $0.87 during trading hours on Friday, reaching $27.81. 1,804,013 shares of the stock were exchanged, compared to its average volume of 2,753,227. The company has a market cap of $4.53 billion, a P/E ratio of 99.32, a price-to-earnings-growth ratio of 1.85 and a beta of 0.98. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. Envista has a twelve month low of $14.72 and a twelve month high of $30.42. The stock has a 50 day moving average of $27.16 and a two-hundred day moving average of $23.41.
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Thursday, February 5th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. Envista’s quarterly revenue was up 15.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts expect that Envista will post 1 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on NVST shares. Wells Fargo & Company upped their price objective on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a report on Friday, February 6th. Robert W. Baird set a $30.00 price objective on shares of Envista in a report on Friday, February 6th. Evercore set a $30.00 price objective on shares of Envista in a report on Wednesday, April 8th. Piper Sandler reiterated a “neutral” rating and issued a $25.00 price objective (up from $21.00) on shares of Envista in a report on Friday, February 6th. Finally, Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Seven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $27.69.
View Our Latest Analysis on Envista
Envista Company Profile
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.